# Ovid Therapeutics Inc.: Form 8-K, filed Mar 8, 2024

- Company: [Ovid Therapeutics Inc.](/companies/ovid.md) (CIK 1636651)
- Form: 8-K
- Filed: 2024-03-08
- Accepted by EDGAR: Mar 8, 2024, 08:20 ET
- Period: 2024-03-08
- Accession: 0001628280-24-009807
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636651/000162828024009807/ovid-20240308.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636651/000162828024009807/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636651/000162828024009807/ovid-20240308.htm

Filed Mar 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-009807. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.